ACTG Publications

Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.Abbas, Ume L ; Anderson, Roy M ; Mellors, John W2006 Apr 15J Acquir Immune Defic Syndr541
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.Aberg, Judith A ; Rosenkranz, Susan L ; Fichtenbaum, Carl J ; Alston, Beverly L ; Brobst, Susan W ; Segal, Yoninah ; Gerber, John G ; ACTG A5108 team2006 Mar 21AIDS520
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.Abraham, Alison G ; Lau, Bryan ; Deeks, Steven ; Moore, Richard D ; Zhang, Jinbing ; Eron, Joseph ; Harrigan, Richard ; Gill, M John ; Kitahata, Mari ; Klein, Marina ; Napravnik, Sonia ; Rachlis, Anita ; Rodriguez, Benigno ; Rourke, Sean ; Benson, Constance ; Bosch, Ron ; Collier, Ann ; Gebo, Kelly ; Goedert, James ; Hogg, Robert ; Horberg2011 Sep 15Am J Epidemiol6174
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?Abu-Raddad, Laith J ; Barnabas, Ruanne V ; Janes, Holly ; Weiss, Helen A ; Kublin, James G ; Longini, Ira M ; Wasserheit, Judith N ; HIV Viral Load Working Group2013 Mar 27AIDS627
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
Similar changes in neuropsychological functioning in english and spanish speaking HIV patients.Akpa, Onoja ; Miyahara, Sachiko ; Taiwo, Babafemi ; Evans, Scott ; Berzins, Baiba ; Robertson, Kevin2018 SepBrain Behav98
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Albrecht, Mary ; Mukherjee, A Lisa ; Tierney, Camlin ; Morse, Gene D ; Dykes, Carrie ; Klingman, Karin L ; Demeter, Lisa M2011 Jul-AugHIV Clin Trials412
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.Almeida, Coral-Ann M ; Bronke, Corine ; Roberts, Steven G ; McKinnon, Elizabeth ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Carlson, Jonathan ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Heckerman, David ; Mallal, Simon ; John, Mina2011 Sep 1J Immunol5187
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.Almeida, Coral-Ann M ; Roberts, Steven G ; Laird, Rebecca ; McKinnon, Elizabeth ; Ahmad, Imran ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Heckerman, David ; Mallal, Simon ; John, Mina2010 Aug 23Vaccine3728
A comparison of tests for restricted orderings in the three-class case.Alonzo, Todd A ; Nakas, Christos T ; Yiannoutsos, Constantin T ; Bucher, Sherri2009 Mar 30Stat Med728
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Amorosa, Valerianna K ; Luetkemeyer, Anne ; Kang, Minhee ; Johnson, Victoria A ; Umbleja, Triin ; Haas, David W ; Yesmin, Suria ; Bardin, Matthew C ; Chung, Ray T ; Alston-Smith, Beverly ; Tebas, Pablo ; Peters, Marion G2013 Nov-DecHIV Clin Trials614
Factors associated with early study discontinuation in AACTG studies, DACS 200.Andersen, Janet W ; Fass, Robert ; van der Horst, Charles2007 SepContemp Clin Trials528
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Anderson, Jeffrey A ; Jiang, Hongyu ; Ding, Xiao ; Petch, Leslie ; Journigan, Terri ; Fiscus, Susan A ; Haubrich, Richard ; Katzenstein, David ; Swanstrom, Ronald ; Gulick, Roy M ; AIDS Clinical Trials Group Study 359 Protocol Team2008 MayAIDS Res Hum Retroviruses524
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Andrade, Adriana ; Guedj, Jeremie ; Rosenkranz, Susan L ; Lu, Darlene ; Mellors, John ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M ; ACTG A5249s protocol team2015 Nov 28AIDS1829
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.Andrade, Adriana ; Rosenkranz, Susan L ; Cillo, Anthony R ; Lu, Darlene ; Daar, Eric S ; Jacobson, Jeffrey M ; Lederman, Michael ; Acosta, Edward P ; Campbell, Thomas ; Feinberg, Judith ; Flexner, Charles ; Mellors, John W ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5248 Team2013 SepJ Infect Dis6208
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy.Angelidou, Konstantia ; Hunt, Peter W ; Landay, Alan L ; Wilson, Cara C ; Rodriguez, Benigno ; Deeks, Steven G ; Bosch, Ronald J ; Lederman, Michael M2018 Jun 20J Infect Dis2218
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.Anthony, D D ; Umbleja, T ; Aberg, J A ; Kang, M ; Medvik, K ; Lederman, M M ; Peters, M G ; Koziel, M J ; Overton, E T2011 Apr 27Vaccine1929
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.Anthony, Donald D ; Conry, Sara J ; Medvik, Kathy ; Sandhya Rani, M R ; Falck-Ytter, Yngve ; Blanton, Ronald E ; Lederman, Michael M ; Rodriguez, Benigno ; Landay, Alan L ; Sandberg, Johan K2012 Sep 15J Infect Dis6206
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Asmelash, Aida ; Zheng, Yu ; Kaloustian, Kara Wools ; Shaffer, Douglas ; Sawe, Fred ; Ogwu, Anthony ; Salata, Robert ; Currier, Judith ; Hughes, Michael D ; Lockman, Shahin2014BMC Infect Dis14
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.Asmuth, David M ; Murphy, Robert L ; Rosenkranz, Susan L ; Lertora, Juan J L ; Kottilil, Shyam ; Cramer, Yoninah ; Chan, Ellen S ; Schooley, Robert T ; Rinaldo, Charles R ; Thielman, Nathan ; Li, Xiao-Dong ; Wahl, Sharon M ; Shore, Jessica ; Janik, Jennifer ; Lempicki, Richard A ; Simpson, Yaa ; Pollard, Richard B ; AIDS Clinical Trials Gr2010 Jun 1J Infect Dis11201
Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.Atkinson, Benjamin E ; Krishnan, Supriya ; Cox, Gary ; Hulgan, Todd ; Collier, Ann C2013PLoS One68
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Aweeka, F T ; Kang, M ; Yu, J-Y ; Lizak, P ; Alston, B ; Chung, R T ; AIDS Clinical Trials Group 5092s Study Team2007 JulHIV Med58
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.Aweeka, Francesca T ; Rosenkranz, Susan L ; Segal, Yoninah ; Coombs, Robert W ; Bardeguez, Arlene ; Thevanayagam, Lourdes ; Lizak, Patricia ; Aberg, Judith ; Watts, D Heather ; NIAID AIDS Clinical Trials Group2006 Sep 11AIDS1420